Although last year’s vaccines protected against SARS-CoV-2 XBB-sublineage strains, “SARS-CoV-2 continues to evolve, and since winter 2023–2024, Omicron JN.1 lineage strains of SARS-CoV-2, including ...

Investing in Real Assets with BREA ETF Brompton Sustainable Real Assets Dividend ETF (Ticker: BREA) is an actively managed, ...

Presentations highlight momentum of Pfizer's portfolio of infectious disease prevention and treatment options NEW YORK, October 8, 2024 - Pfizer Inc ...

Pfizer Inc. (NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2024 congress, held ...